Title: Establishing of a risk prediction model for metabolic dysfunction associated steatotic liver
disease: a retrospective cohort study
Version: 2 Date: 05 Nov 2024
Reviewer's report:
The authors have mainly addressed critiques.  It would be useful to have clarification on one
issue
the authors state
We appreciate the Reviewer’s comments. All subjects underwent abdominal
ultrasound examinations at baseline and during each follow-up. Additionally, all relevant
indicators involved in the MASLD diagnostic criteria are
complete
It  would be useful to define this better in the methods.  I assume at baseline there was no steatosis
and participants developed steatosis over a 4 year follow up period?
a table showing the development of fatty liver at each annual US would be helpful as well
Title: Establishing of a risk prediction model for metabolic dysfunction associated steatotic liver
disease: a retrospective cohort study
Version: 2 Date: 05 Nov 2024
Reviewer's report:
The authors have mainly addressed critiques.  It would be useful to have clarification on one
issue
the authors state
We appreciate the Reviewer’s comments. All subjects underwent abdominal
ultrasound examinations at baseline and during each follow-up. Additionally, all relevant
indicators involved in the MASLD diagnostic criteria are
complete
It  would be useful to define this better in the methods.  I assume at baseline there was no steatosis
and participants developed steatosis over a 4 year follow up period?
a table showing the development of fatty liver at each annual US would be helpful as well
Please review this paper.
user
Title: Establishing of a risk prediction model for metabolic dysfunction associated steatotic liver
disease: a retrospective cohort study
Version: 2 Date: 05 Nov 2024
Reviewer's report:
The authors have mainly addressed critiques.  It would be useful to have clarification on one
issue
the authors state
We appreciate the Reviewer’s comments. All subjects underwent abdominal
ultrasound examinations at baseline and during each follow-up. Additionally, all relevant
indicators involved in the MASLD diagnostic criteria are
complete
It  would be useful to define this better in the methods.  I assume at baseline there was no steatosis
and participants developed steatosis over a 4 year follow up period?
a table showing the development of fatty liver at each annual US would be helpful as well
assistant